IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of cash flow

in CHF 1 000

Notes

01.01.–31.03.2024

01.01.–31.03.2023

Cash flows from operating activities

Proceeds from sales of securities

3

161 515

226 681

Purchase of securities

3

(81 566)

(12 907)

Payments for services

(8 667)

(10 656)

Income taxes paid

(35)

(32)

Total cash flows from operating activities

71 247

203 086

Cash flows from financing activities

Dividend

(109 692)

(156 311)

Proceeds from borrowings

4

39 800

Repayment of borrowings

4

(47 500)

Interest payments

(1 435)

(1 108)

Total cash flows from financing activities

(71 327)

(204 919)

Foreign exchange difference

(16)

644

Change in cash and cash equivalents

(96)

(1 189)

Cash and cash equivalents at the beginning of the period

501

1 948

Cash and cash equivalents at the end of the period

405

759

The notes are an integral part of the condensed consolidated interim financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer